Mark M Fuster
Overview
Explore the profile of Mark M Fuster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1742
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spliid C, Mehta S, Fuster M, Martino C, Morris C, Lee N, et al.
Glycobiology
. 2024 Oct;
34(12.
PMID: 39361890
The human oral cavity and upper airway serves as an early barrier and reservoir in the transmission of SARS-CoV-2. Saliva in this microenvironment may serve as a key host factor...
2.
Fuster M
Front Oncol
. 2024 Aug;
14:1417621.
PMID: 39165679
An array of published cell-based and small animal studies have demonstrated a variety of exposures of cancer cells or experimental carcinomas to electromagnetic (EM) wave platforms that are non-ionizing and...
3.
Johns S, Gupta P, Lee Y, Friend J, Fuster M
Biophys J
. 2023 Nov;
122(22):4425-4439.
PMID: 37992690
Mechanisms by which electric (E) or magnetic (B) fields might be harnessed to affect tumor cell behavior remain poorly defined, presenting a barrier to translation. We hypothesized in early studies...
4.
Yu J, Non A, Heinrich E, Gu W, Alcock J, Moya E, et al.
Front Physiol
. 2022 Aug;
13:885295.
PMID: 36035495
The ability to respond rapidly to changes in oxygen tension is critical for many forms of life. Challenges to oxygen homeostasis, specifically in the contexts of evolutionary biology and biomedicine,...
5.
Kim S, Gupta P, Johns S, Zuniga E, Teijaro J, Fuster M
Sci Rep
. 2022 Mar;
12(1):5382.
PMID: 35354833
Survival from influenza A virus (IAV) infection largely depends on an intricate balance between pathogen clearance and immunomodulation in the lung. We demonstrate that genetic alteration of the glycan heparan...
6.
Indralingam C, Gutierrez-Gonzalez A, Johns S, Tsui T, Cannon D, Fuster M, et al.
Physiol Rep
. 2022 Feb;
10(3):e15185.
PMID: 35150208
Pulmonary arterial hypertension (PAH) is associated with significant morbidity and mortality. PAH is characterized by pulmonary artery remodeling, elevated right ventricular pressure (RVP) and, ultimately, cardiac failure. Pulmonary endothelial cells...
7.
Kim S, Johns S, Gupta P, Varki N, Fuster M
Neoplasia
. 2021 Oct;
23(11):1137-1143.
PMID: 34715561
Early lung carcinoma development may be modulated by innate host cellular mechanisms that promote tumor growth and invasion. We recently identified how a loss-of-function mutation in the glycan sulfating enzyme...
8.
Tsai J, Saad O, Magesh S, Xu J, Lee A, Li W, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439379
Tobacco is the primary etiologic agent in worsened lung squamous cell carcinoma (LUSC) outcomes. Meanwhile, it has been shown that etiologic agents alter enhancer RNAs (eRNAs) expression. Therefore, we aimed...
9.
Kim S, Jin W, Sood A, Montgomery D, Grant O, Fuster M, et al.
Antiviral Res
. 2020 Jul;
181:104873.
PMID: 32653452
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has resulted in a pandemic and continues to spread around the globe at an unprecedented rate. To date, no effective therapeutic is available...
10.
Ashdown C, Johns S, Aminov E, Unanian M, Connacher W, Friend J, et al.
Biophys J
. 2020 Mar;
118(7):1552-1563.
PMID: 32142642
Tumor cells express a unique cell surface glycocalyx with upregulation of sulfated glycosaminoglycans and charged glycoproteins. Little is known about how electromagnetic fields interact with this layer, particularly with regard...